Home / Recalls / Glenmark Pharmaceuticals Inc., USA / D-0472-2024

D-0472-2024 Class II Ongoing

Recalled by Glenmark Pharmaceuticals Inc., USA — Mahwah, NJ

Recall Details

Product Type: Drugs
Report Date: May 1, 2024
Initiation Date: April 17, 2024
Termination Date: N/A
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 3,264 bottles

Product Description

Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ, 07430, Product of India, NDC 68462-562-01.

Reason for Recall

Failed Dissolution Specifications

Distribution Pattern

Nationwide in the USA.

Code Information

Lot #: 17221312, Exp. 5/31/2024

Other recalls by Glenmark Pharmaceuticals Inc., USA

D-0246-2026 Class II — Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards (December 30, 2025)
D-0199-2026 Class III — Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, 2.5 mg/6.25 mg, packag (November 21, 2025)
D-0222-2026 Class III — Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmac (November 18, 2025)
D-0662-2025 Class II — Azelaic Acid Gel, 15%, 50 grams, For Topical Use Only, Rx only, Manufactured by: (September 17, 2025)
D-0021-2026 Class II — Viorele, Desogestrel and Ethinyl Estradiol, USP, 0.15 mg/ 0.02 mg and Ethinyl Es (September 3, 2025)
D-0583-2025 Class II — Theophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufact (August 8, 2025)
D-0577-2025 Class II — Carvedilol Tablets, USP, 3.125 mg, Packaged as: a)500-count bottle, NDC 68462-16 (August 7, 2025)
D-0579-2025 Class II — Carvedilol Tablets, USP, 25 mg, 500-count bottle, Rx only, Manufactured by: Glen (August 7, 2025)
D-0578-2025 Class II — Carvedilol Tablets, USP, 12.5 mg, 500-count bottle, Rx only, Manufactured by: Gl (August 7, 2025)
D-0588-2025 Class II — Carvedilol Tablets, USP, 25 mg, 500 Tablets per carton, Rx Only, Manufactured by (August 6, 2025)